# GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

> **NCT03202004** · PHASE3 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** GSK2894512 1% cream
- **DRUG:** Vehicle cream

## Key facts

- **NCT ID:** NCT03202004
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01-22
- **Primary completion:** 2018-09-28
- **Final completion:** 2018-09-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The decision not to progress the planned Phase 3 studies is a business decision based on the need to prioritise and focus resources within GSK.
- **Last updated:** 2017-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03202004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03202004, "GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03202004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*